The 18-kDa translocator protein (TSPO) is gaining recognition as a relevant target in
glioblastoma imaging. However, data on the potential prognostic value of TSPO PET …

Purpose Glioma patients, especially recurrent glioma, suffer from a poor prognosis. While
advances to classify glioma on a molecular level improved prognostication at initial …

Purpose 11C-Methionine (11C-MET) PET prognostication of isocitrate dehydrogenase (IDH)
wild type glioblastomas is inadequate as conventional parameters such as standardized …

In glioma patients, complete resection of the contrast-enhancing portion is associated with
improved survival, which, however, cannot be achieved in a considerable number of …

Purpose The aim of this study was to build and evaluate a prediction model which
incorporates clinical parameters and radiomic features extracted from static as well as …

Background The 18-kDa translocator protein (TSPO) is overexpressed in brain tumours and
represents an interesting target for glioma imaging. 18 F-GE-180, a novel TSPO ligand, has …

Objective The role of amino acid positron emission tomography (PET) in glioma grading and
outcome prognostication has not yet been well established. This is particularly true in the …

Purpose Integrated histomolecular diagnostics of gliomas according to the World Health
Organization (WHO) classification of 2016 has refined diagnostic accuracy and prediction of …

Objective Isocitrate dehydrogenase (IDH) mutation, telomerase reverse transcriptase (TERT)
promoter mutation and O 6-methylguanine-DNA methyltransferase (MGMT) promoter …

This study aimed whether the uptake of amino tracer positron emission tomography (PET)
can be used as an additional imaging biomarker to estimate the prognosis of glioma …